Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

Istanbul University · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
focal segmental glomerulosclerosis, minimal change disease, rituximab, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 868439
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.